|
Pathway name | LS_vs_control |
|
Alpha6 beta4 integrin signaling pathway | 0.793 |
Androgen receptor signaling pathway | 0.528 |
Apoptosis mechanisms | 0.124 |
B-cell receptor signaling pathway | 0.023 |
G1 to S cell cycle control | 1 |
Cell cycle | 0.487 |
Delta-Notch signaling pathway | 0.226 |
DNA replication | 1 |
EGFR1 signaling pathway | 0.856 |
FAS pathway and stress induction of HSP regulation | 1 |
Focal Adhesion | 0.003 |
G13 signaling pathway | 0.269 |
G protein signaling pathways | 0.258 |
Hedgehog signaling pathway | 1 |
Apoptosis modulation by HSP70 | 1 |
Id signaling pathway | 1 |
IL-1 signaling pathway | 1 |
IL-2 signaling pathway | 0.327 |
IL-3 signaling pathway | 0.371 |
IL-4 signaling pathway | 0.589 |
IL-5 signaling pathway | 0.576 |
IL-6 signaling pathway | 1 |
IL-7 signaling pathway | 0.498 |
IL-9 signaling pathway | 1 |
Human insulin signaling | 0.387 |
Integrin-mediated cell adhesion | 0.363 |
Kit receptor signaling pathway | 0.051 |
MAPK cascade | 1 |
MAPK signaling pathway | 0.011 |
mRNA processing (Homo sapiens) | 0.014 |
Notch signaling pathway | 0.191 |
Ovarian infertility genes | 1 |
p38 MAPK signaling pathway (BioCarta) | 0.108 |
Regulation of actin cytoskeleton | 0.834 |
Eukaryotic transcription initiation | 0.511 |
Signal transduction of S1P | 0.384 |
Signaling of hepatocyte growth factor receptor | 1 |
T cell receptor signaling pathway | 0.243 |
TGF-beta receptor signaling pathway | 0.095 |
TGF beta signaling pathway | 0 |
TNF-alpha/NF-B signaling pathway | 0.752 |
Translation factors | 0.368 |
Wnt signaling pathway | 0.15 |
Wnt signaling pathway | 0.051 |
Acetylcholine synthesis | 1 |
Alanine and aspartate metabolism | ā |
Biogenic amine synthesis | 1 |
Cholesterol biosynthesis | 0.644 |
Eicosanoid synthesis | 1 |
Electron transport chain | 0.013 |
Fatty acid beta oxidation 1 | 0.403 |
Fatty acid beta oxidation 2 | 1 |
Fatty acid beta oxidation 3 | 1 |
Beta oxidation meta MAPP | 0.264 |
Fatty acid omega oxidation | 0.687 |
Fatty acid biosynthesis | 0.426 |
Glucocorticoid and mineralcorticoid metabolism | 1 |
Glutathione metabolism | 0.399 |
Glycogen metabolism | 0.261 |
Glycolysis and gluconeogenesis | 0.235 |
Heme biosynthesis | 1 |
TCA cycle | 0.24 |
Mitochondrial LC-fatty acid beta-oxidation | 0.635 |
Nuclear receptors in lipid metabolism and toxicity | 0.389 |
Nucleotide metabolism | 0.622 |
Pentose phosphate pathway | 1 |
Prostaglandin synthesis and regulation | 1 |
Statin pathway (PharmGKB) | 1 |
Steroid biosynthesis | 1 |
Synthesis and degradation of ketone bodies | 1 |
Triacylglyceride synthesis | 0.419 |
Tryptophan metabolism | 0.501 |
Beta oxidation of unsaturated fatty acids | 1 |
Urea cycle and metabolism of amino groups | ā |
GPCRs, class A rhodopsin-like | 0.317 |
GPCRs, class B secretin-like | 1 |
GPCRs, class C metabotropic glutamate, pheromone | 1 |
GPCRs, other | 1 |
Matrix metalloproteinases | 0.652 |
Monoamine GPCRs | 1 |
Nuclear receptors | 1 |
Nucleotide GPCRs | 1 |
Peptide GPCRs | 0.081 |
Cytoplasmic ribosomal proteins | 0.025 |
Small ligand GPCRs | 1 |
ACE inhibitor pathway (Homo sapiens) | 0.254 |
Adipogenesis human | 0.101 |
Blood clotting cascade | 0.155 |
Calcium regulation in the cardiac cell | 0.431 |
Circadian exercise | 0.754 |
Complement activation and classical pathway | 0.646 |
Complement activation and classical pathway | 0.022 |
Cytokines and inflammatory response (BioCarta) | 0 |
Hypertrophy model | 0 |
Inflammatory response pathway | 0.054 |
Irinotecan pathway (Homo sapiens) | 0.685 |
Oxidative stress | 0.402 |
Proteasome degradation | 0.278 |
Myometrial relaxation and contraction pathways | 0 |
Striated muscle contraction | 0.427 |
|